Global Cell Line Engineering Services 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08252123

Publication Date:

August 28, 2024

Pages:

129

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Cell Line Engineering Services market size was valued at US$ million in 2023. With growing demand in downstream market, the Cell Line Engineering Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cell Line Engineering Services market. Cell Line Engineering Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell Line Engineering Services. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell Line Engineering Services market.
Cell line engineering services is a biotechnology service that utilizes gene editing and cell culture technologies to edit and modify cells for various research and application needs. In this service, professional scientists design suitable gene editing schemes based on the customer's requirements and use gene editing tools such as CRISPR/Cas9 to precisely modify, insert, or delete the target gene sequence. Through specific cell culture techniques, the modified cells can obtain superior phenotypes and characteristics, such as higher product yield, better growth characteristics, and higher immune response.
Cell line engineering services are mainly applied in the field of biomedicine, such as drug screening, immunotherapy, gene therapy, etc. Furthermore, since this technology can be applied to various types of cells and animal and plant cells, it can also be applied in fields such as food and agriculture, such as improving the disease resistance of some plants and improving the quality of certain meat products.
Key Features:
The report on Cell Line Engineering Services market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Cell Line Engineering Services market. It may include historical data, market segmentation by Type (e.g., Small scale, Medium scale), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell Line Engineering Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell Line Engineering Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cell Line Engineering Services industry. This include advancements in Cell Line Engineering Services technology, Cell Line Engineering Services new entrants, Cell Line Engineering Services new investment, and other innovations that are shaping the future of Cell Line Engineering Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell Line Engineering Services market. It includes factors influencing customer ' purchasing decisions, preferences for Cell Line Engineering Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell Line Engineering Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell Line Engineering Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell Line Engineering Services market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell Line Engineering Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell Line Engineering Services market.
麻豆原创 Segmentation:
Cell Line Engineering Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Small scale
Medium scale
Large scale
Segmentation by application
Bio-pharmaceutical
Medical Treatment
Medical Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD BioSciences
Curia
Horizo鈥嬧€媙 Discovery
Multispan, Inc.
System Biosciences (SBI)
Biocon
Cyagen
Analytical Biological Services (ABS)
Celvab
Boston Institute of Biotechnology
ALSTEM
ProMab Biotechnologies
Cytosurge AG
Merck
Thermo Fisher Scientific
WuXi Advanced Therapies
GenScript Biotech Corporation (HK.1548)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Cell Line Engineering Services 麻豆原创 Size 2019-2030
2.1.2 Cell Line Engineering Services 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cell Line Engineering Services Segment by Type
2.2.1 Small scale
2.2.2 Medium scale
2.2.3 Large scale
2.3 Cell Line Engineering Services 麻豆原创 Size by Type
2.3.1 Cell Line Engineering Services 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell Line Engineering Services 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Cell Line Engineering Services Segment by Application
2.4.1 Bio-pharmaceutical
2.4.2 Medical Treatment
2.4.3 Medical Research
2.4.4 Others
2.5 Cell Line Engineering Services 麻豆原创 Size by Application
2.5.1 Cell Line Engineering Services 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell Line Engineering Services 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Cell Line Engineering Services 麻豆原创 Size by Player
3.1 Cell Line Engineering Services 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Cell Line Engineering Services Revenue by Players (2019-2024)
3.1.2 Global Cell Line Engineering Services Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cell Line Engineering Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Line Engineering Services by Regions
4.1 Cell Line Engineering Services 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Cell Line Engineering Services 麻豆原创 Size Growth (2019-2024)
4.3 APAC Cell Line Engineering Services 麻豆原创 Size Growth (2019-2024)
4.4 Europe Cell Line Engineering Services 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Cell Line Engineering Services 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Cell Line Engineering Services 麻豆原创 Size by Country (2019-2024)
5.2 Americas Cell Line Engineering Services 麻豆原创 Size by Type (2019-2024)
5.3 Americas Cell Line Engineering Services 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Line Engineering Services 麻豆原创 Size by Region (2019-2024)
6.2 APAC Cell Line Engineering Services 麻豆原创 Size by Type (2019-2024)
6.3 APAC Cell Line Engineering Services 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Line Engineering Services by Country (2019-2024)
7.2 Europe Cell Line Engineering Services 麻豆原创 Size by Type (2019-2024)
7.3 Europe Cell Line Engineering Services 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Line Engineering Services by Region (2019-2024)
8.2 Middle East & Africa Cell Line Engineering Services 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Cell Line Engineering Services 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Cell Line Engineering Services 麻豆原创 Forecast
10.1 Global Cell Line Engineering Services Forecast by Regions (2025-2030)
10.1.1 Global Cell Line Engineering Services Forecast by Regions (2025-2030)
10.1.2 Americas Cell Line Engineering Services Forecast
10.1.3 APAC Cell Line Engineering Services Forecast
10.1.4 Europe Cell Line Engineering Services Forecast
10.1.5 Middle East & Africa Cell Line Engineering Services Forecast
10.2 Americas Cell Line Engineering Services Forecast by Country (2025-2030)
10.2.1 United States Cell Line Engineering Services 麻豆原创 Forecast
10.2.2 Canada Cell Line Engineering Services 麻豆原创 Forecast
10.2.3 Mexico Cell Line Engineering Services 麻豆原创 Forecast
10.2.4 Brazil Cell Line Engineering Services 麻豆原创 Forecast
10.3 APAC Cell Line Engineering Services Forecast by Region (2025-2030)
10.3.1 China Cell Line Engineering Services 麻豆原创 Forecast
10.3.2 Japan Cell Line Engineering Services 麻豆原创 Forecast
10.3.3 Korea Cell Line Engineering Services 麻豆原创 Forecast
10.3.4 Southeast Asia Cell Line Engineering Services 麻豆原创 Forecast
10.3.5 India Cell Line Engineering Services 麻豆原创 Forecast
10.3.6 Australia Cell Line Engineering Services 麻豆原创 Forecast
10.4 Europe Cell Line Engineering Services Forecast by Country (2025-2030)
10.4.1 Germany Cell Line Engineering Services 麻豆原创 Forecast
10.4.2 France Cell Line Engineering Services 麻豆原创 Forecast
10.4.3 UK Cell Line Engineering Services 麻豆原创 Forecast
10.4.4 Italy Cell Line Engineering Services 麻豆原创 Forecast
10.4.5 Russia Cell Line Engineering Services 麻豆原创 Forecast
10.5 Middle East & Africa Cell Line Engineering Services Forecast by Region (2025-2030)
10.5.1 Egypt Cell Line Engineering Services 麻豆原创 Forecast
10.5.2 South Africa Cell Line Engineering Services 麻豆原创 Forecast
10.5.3 Israel Cell Line Engineering Services 麻豆原创 Forecast
10.5.4 Turkey Cell Line Engineering Services 麻豆原创 Forecast
10.5.5 GCC Countries Cell Line Engineering Services 麻豆原创 Forecast
10.6 Global Cell Line Engineering Services Forecast by Type (2025-2030)
10.7 Global Cell Line Engineering Services Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 CD BioSciences
11.1.1 CD BioSciences Company Information
11.1.2 CD BioSciences Cell Line Engineering Services Product Offered
11.1.3 CD BioSciences Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 CD BioSciences Main Business Overview
11.1.5 CD BioSciences Latest Developments
11.2 Curia
11.2.1 Curia Company Information
11.2.2 Curia Cell Line Engineering Services Product Offered
11.2.3 Curia Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Curia Main Business Overview
11.2.5 Curia Latest Developments
11.3 Horizo鈥嬧€媙 Discovery
11.3.1 Horizo鈥嬧€媙 Discovery Company Information
11.3.2 Horizo鈥嬧€媙 Discovery Cell Line Engineering Services Product Offered
11.3.3 Horizo鈥嬧€媙 Discovery Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Horizo鈥嬧€媙 Discovery Main Business Overview
11.3.5 Horizo鈥嬧€媙 Discovery Latest Developments
11.4 Multispan, Inc.
11.4.1 Multispan, Inc. Company Information
11.4.2 Multispan, Inc. Cell Line Engineering Services Product Offered
11.4.3 Multispan, Inc. Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Multispan, Inc. Main Business Overview
11.4.5 Multispan, Inc. Latest Developments
11.5 System Biosciences (SBI)
11.5.1 System Biosciences (SBI) Company Information
11.5.2 System Biosciences (SBI) Cell Line Engineering Services Product Offered
11.5.3 System Biosciences (SBI) Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 System Biosciences (SBI) Main Business Overview
11.5.5 System Biosciences (SBI) Latest Developments
11.6 Biocon
11.6.1 Biocon Company Information
11.6.2 Biocon Cell Line Engineering Services Product Offered
11.6.3 Biocon Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Biocon Main Business Overview
11.6.5 Biocon Latest Developments
11.7 Cyagen
11.7.1 Cyagen Company Information
11.7.2 Cyagen Cell Line Engineering Services Product Offered
11.7.3 Cyagen Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Cyagen Main Business Overview
11.7.5 Cyagen Latest Developments
11.8 Analytical Biological Services (ABS)
11.8.1 Analytical Biological Services (ABS) Company Information
11.8.2 Analytical Biological Services (ABS) Cell Line Engineering Services Product Offered
11.8.3 Analytical Biological Services (ABS) Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Analytical Biological Services (ABS) Main Business Overview
11.8.5 Analytical Biological Services (ABS) Latest Developments
11.9 Celvab
11.9.1 Celvab Company Information
11.9.2 Celvab Cell Line Engineering Services Product Offered
11.9.3 Celvab Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Celvab Main Business Overview
11.9.5 Celvab Latest Developments
11.10 Boston Institute of Biotechnology
11.10.1 Boston Institute of Biotechnology Company Information
11.10.2 Boston Institute of Biotechnology Cell Line Engineering Services Product Offered
11.10.3 Boston Institute of Biotechnology Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Boston Institute of Biotechnology Main Business Overview
11.10.5 Boston Institute of Biotechnology Latest Developments
11.11 ALSTEM
11.11.1 ALSTEM Company Information
11.11.2 ALSTEM Cell Line Engineering Services Product Offered
11.11.3 ALSTEM Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 ALSTEM Main Business Overview
11.11.5 ALSTEM Latest Developments
11.12 ProMab Biotechnologies
11.12.1 ProMab Biotechnologies Company Information
11.12.2 ProMab Biotechnologies Cell Line Engineering Services Product Offered
11.12.3 ProMab Biotechnologies Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 ProMab Biotechnologies Main Business Overview
11.12.5 ProMab Biotechnologies Latest Developments
11.13 Cytosurge AG
11.13.1 Cytosurge AG Company Information
11.13.2 Cytosurge AG Cell Line Engineering Services Product Offered
11.13.3 Cytosurge AG Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Cytosurge AG Main Business Overview
11.13.5 Cytosurge AG Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Cell Line Engineering Services Product Offered
11.14.3 Merck Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Information
11.15.2 Thermo Fisher Scientific Cell Line Engineering Services Product Offered
11.15.3 Thermo Fisher Scientific Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Thermo Fisher Scientific Main Business Overview
11.15.5 Thermo Fisher Scientific Latest Developments
11.16 WuXi Advanced Therapies
11.16.1 WuXi Advanced Therapies Company Information
11.16.2 WuXi Advanced Therapies Cell Line Engineering Services Product Offered
11.16.3 WuXi Advanced Therapies Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 WuXi Advanced Therapies Main Business Overview
11.16.5 WuXi Advanced Therapies Latest Developments
11.17 GenScript Biotech Corporation (HK.1548)
11.17.1 GenScript Biotech Corporation (HK.1548) Company Information
11.17.2 GenScript Biotech Corporation (HK.1548) Cell Line Engineering Services Product Offered
11.17.3 GenScript Biotech Corporation (HK.1548) Cell Line Engineering Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 GenScript Biotech Corporation (HK.1548) Main Business Overview
11.17.5 GenScript Biotech Corporation (HK.1548) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.